↓ Skip to main content

Pimozide for schizophrenia or related psychoses

Overview of attention for article published in Cochrane database of systematic reviews, November 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

blogs
1 blog
twitter
10 tweeters
weibo
1 weibo user
facebook
1 Facebook page
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
227 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Pimozide for schizophrenia or related psychoses
Published in
Cochrane database of systematic reviews, November 2013
DOI 10.1002/14651858.cd001949.pub3
Pubmed ID
Authors

Meghana Mothi, Stephanie Sampson

Abstract

Pimozide, formulated in the 1960s, continues to be marketed for the care of people with schizophrenia or related psychoses such as delusional disorder. It has been associated with cardiotoxicity and sudden unexplained death. Electrocardiogram monitoring is now required before and during use.

Twitter Demographics

The data shown below were collected from the profiles of 10 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 227 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Unknown 226 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 50 22%
Researcher 31 14%
Student > Ph. D. Student 30 13%
Student > Bachelor 28 12%
Student > Doctoral Student 16 7%
Other 39 17%
Unknown 33 15%
Readers by discipline Count As %
Medicine and Dentistry 75 33%
Psychology 36 16%
Nursing and Health Professions 23 10%
Social Sciences 13 6%
Pharmacology, Toxicology and Pharmaceutical Science 9 4%
Other 28 12%
Unknown 43 19%

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 July 2017.
All research outputs
#863,604
of 12,667,610 outputs
Outputs from Cochrane database of systematic reviews
#2,853
of 10,396 outputs
Outputs of similar age
#14,198
of 177,634 outputs
Outputs of similar age from Cochrane database of systematic reviews
#33
of 114 outputs
Altmetric has tracked 12,667,610 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,396 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.3. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 177,634 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 114 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.